The patient had neither undergone any medical or surgical procedures in the past
These are game-changing medications, says Shauna Levy, M.D., an obesity medicine physician at the Tulane University Medical Center in New Orleans and the medical director of Tulanes Bariatric and Weight Loss Center
Lancet 399(10333):22232235 Weir MR, Bakris GL, Bushinsky DA et al (2015) Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
[El mercado del bienestar] ha seguido aprovechndose de los desesperados, y estas son personas que tienen un acceso deficiente, dijo Butsch, los pacientes con obesidad siempre han tenido poco acceso a los medicamentos para la obesidad
Ayoub M, Aibani R, Dodd T, Ceesay M, Bhinder M, Faris C, et al
It is not approved for medical, therapeutic, veterinary or diagnostic use and is not intended for human consumption or clinical application